PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Jun-2023 SCTbio and Cyto-care collaborate to improve cell therapy cryopreservation and logistics capabilities in Europe SCTbio
15-Jun-2023 REAL-WORLD RESULTS DEMONSTRATE HIGH RESPONSE RATE AND DURABLE REMISSION WITH KITE CAR T-CELL THERAPIES FOR R/R MCL AND FL AT EHA 2023 Kite, a Gilead Company
15-Jun-2023 Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency Takeda
15-Jun-2023 CD Formulation Expands Its Healthcare Product Development and OEM/ODM Services CD Formulation
14-Jun-2023 Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy Alfa Chemistry
13-Jun-2023 Invizius announces ‘Angry Blood’ Haemodialysis Study and recruits its 300th patient. Invizius
13-Jun-2023 CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research CD ComputaBio
12-Jun-2023 Modus Therapeutics presented new data on sevuparin demonstrating its potential to treat anemia related to chronic diseases at the annual European Hematology Association Congress Modus Therapeutics
12-Jun-2023 Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-NPC Program Bloomsbury Genetic Therapies
12-Jun-2023 Theolytics Presents Data on THEO-260 for stromal rich carcinomas at ASCO and on THEO-310 for myeloma at EHA Theolytics
08-Jun-2023 Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease Coya Therapeutics, Inc.
08-Jun-2023 Clasado announces synbiotic partnership with Probi AB Clasado
07-Jun-2023 SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance SANTERO THERAPEUTICS
07-Jun-2023 Connecta Therapeutics starts clinical trials for its Fragile X syndrome drug Connecta Therapeutics
06-Jun-2023 Almaden Genomics Names Ellen Gordon Vice President, Head of Business Development Almaden Genomics
06-Jun-2023 Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial Evaxion
06-Jun-2023 Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023 Transgene
06-Jun-2023 Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis Tiziana Life Sciences
06-Jun-2023 Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings Benchling
06-Jun-2023 Phastar Statistics Manager Wins Prestigious DIA Award Phastar